Objective: With increasing interest in the role of non-traditional lipid risk factors in coronary artery disease, we undertook this study to relate LDL subclass size and carotid intima-media thickness of the common carotid artery in coronary artery disease patients. Methods: The study was conducted in 106 patients during their fi rst visit (study group I) and after 12 months (study group II). Intima-media thickness of the common carotid artery was determined using B-mode ultrasound. Separation of LDL subclasses was preformed by 3-31 % polyacrylamide gradient gel electrophoresis. Results: LDL 3 was the dominant subclass in both study groups, but there was statistically signifi cant difference in the distribution of dominant LDL subclasses (p<0.01). The mean carotid intima-media thickness was significantly increased (p<0.001) in coronary artery disease patients after 12 months period. There was signifi cant negative correlation between intima-media thickness and LDL size in both study groups (p<0.05). Intima-media thickness was not signifi cantly correlated with plasma lipid concentrations. Multiple regression analyses show that strongest independent predictor of the intima-media thickness variation was diastolic blood pressure, followed by LDL size and age, and accounted for 29 % of the observed variability in intima-media thickness. Conclusion: LDL particle size is independently associated with carotid intima-media thickness in coronary artery disease patients with normal levels of traditional lipid risk. These results imply that small, dense LDL subclasses are an important indicator for assessing atherosclerosis and its progression (Tab. 4, Ref. 39). Full Text in PDF www.elis.sk.
It is well established that elevated circulating concentrations of cholesterol-rich, low-density lipoproteins (LDL) represent a major risk factor for the premature development of coronary artery disease (1) . The LDL fractions have been shown to be heterogeneous in size, density, electric charge, and lipid and apolipoprotein composition (2-6). Analysis of LDL size distribution in normal subject's plasma as well as in dyslipidemic subjects' plasma have revealed that LDL subclasses can be distributed either as monodisperse or polydisperse populations of particles (7-9). It has been shown that small, dense LDL (LDLs) has less affi nity to the LDL receptor and therefore has prolonged residence in plasma. They penetrate the arterial wall easily and bind to intimal proteoglycans, undergo oxidative modifi cation which increases their atherogenicity which is considered as an initial step in the atherosclerosis development (10) .
Several clinical studies indicate that small LDL size is associated with an increased risk of coronary artery disease (CAD) (1) (2) (3) (4) (5) (6) (7) (8) . The Adult Treatment Panel (ATP) III has defi ned emerging risk factors for CAD, including small, dense low-density lipoprotein (LDLs) (11) . LDLs particles are present in families with premature CAD and hyperapobetalipoproteinemia, familial combined hyperlipidemia, familial dyslipidemic hypertension, and metabolic syndrome (12) (13) (14) (15) (16) (17) . Small, dense LDLs are often accompanied by increased triglycerides (TGs) and low high-density lipoproteins (HDL) (18) .
A number of methods have been developed to separate LDL subclasses. Nondenaturing polyacrylamide gradient gel electrophoresis is widely used in clinical studies (2-8). The advantage of this method is the possibility to separate up to 7 subclasses within LDL fraction, according to particle size, and is easy to perform.
Evaluation of carotid intima-media thickness (IMT) using ultrasonogaphy is a validated quantitative method for assessing the presence and severity of atherosclerosis. IMT is increased in groups of patients with several cardiovascular risk factors (advanced age, hypertension, smoking, and male gender (19, 20) . It has been proved that carotid IMT is an independent risk factor for myocardial infarction and stroke, and predicts the progression of CAD (21, 22) .
Carotid atherosclerosis has been associated with high triglyceride levels and low HDL cholesterol, known as "atherogenic lipid profi le" (23, 24) .
Recently, it has been shown that small low-density lipoprotein and LDL particle size are associated with carotid IMT independent of total cholesterol or LDL cholesterol (25, 26) .
In this study we investigated the relationship of LDL size and other risk factors with intima-media thickness (IMT) of the common carotid artery (CCA) in CAD patients with clinically apparent atherosclerosis at their fi rst visit and 12 months after.
Material and methods

Subjects and blood samples collection
Study group I. One hundred and fi ve patients (75 men and 30 women, aged 36 to 74 years) with a history of coronary artery disease were recruited at the time of their fi rst visit at the University Cardiology Clinic, Medical Faculty, Skopje.
The diagnosis of CAD was based on the subjects medical history, clinical signs and symptoms, characteristic electrocardiogram changes, increased concentrations of cardiac enzymes and echocardiography assessment of left ventricular systolic and diastolic function. Hypertension was defi ned as systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, antihypertensive medications, or any combination of these. Individuals with diabetes mellitus, renal diseases, neoplastic disorders, and those treated with lipid-lowering drugs were excluded.
Study group II. Ninety fi ve participants from study group I (68 men and 27 women, aged 41 to 74 years) were analyzed 12 months after their fi rst visit of the Clinic.
The height and weight of each patient was used to calculate body mass index (BMI; kg/m 2 ). The study was performed according to the Helsinki declaration and was approved by the Ethics Committee of the Macedonian Medical Chamber. All subjects signed inform consent forms prior to examination.
Sample preparation
Venous blood for the analysis was obtained after a 12 hour overnight fast and collected into K 3 EDTA containing tubes. After centrifugation at 3000 rpm for 10 minutes, plasma samples were stored at +4 °C within 48 hours. One portion of each sample for LDL subclass separation was stored at -80 °C until analysis within 2 months.
Lipid and apoprotein measurements
All lipid measurements were performed in fresh plasma samples, within 48 hours, kept at +4 °C. Plasma total cholesterol and triglyceride concentrations were examined using enzymatic methods (Randox, Crumlin, UK). Determination of plasma HDL cholesterol concentrations with dextran sulfate-magnesium precipitation was followed by enzymatic determination of cholesterol. The Friedewald formula was used to calculate LDL cholesterol concentrations (27) . ApoA-1, ApoB and Lp(a) concentrations were measured by the immunonephelometry method (DADE Behring, Marburg, Germany).
Non-denaturing polyacrylamide gradient gel electrophoresis
Non-denaturing polyacrylamide 3-31 % gradient gel electrophoresis (PAGE) was performed to separate LDL subclasses and estimates their size. Since sources of specialized Pharmacia GE-2/4 electrophoresis chambers and commercial gels have become uncertain, we used an alternative, Mini-Protean II Electrophoresis Apparatus (BioRad 165-2941, Hercules, CA,USA). Therefore, a new casting protocol was developed and glass cassettes fi tting the BioRad electrophoresis chamber were made in our laboratory. The gradient gel characteristics and all details of the method have been presented in our previous publication (28) . This new gel format allowed LDL and HDL subclasses separation on the same gel and thus duplication of work was avoided.
Plasma samples and human standard were prestained for 18 hours with Sudan Black B for analyses of cholesterol-stained lipoproteins. Ten samples were loaded to each gel. Human plasma standard, high molecular weight protein standard (HMW; 17-0445-02, Pharmacia Biotech, Uppsala, Sweden) and carboxilated polystyrene microspheres (beads; Duke Scientifi c, Palo Alto, CA) were loaded to calibrate for particle size. Beads were prestained with Sudan Black B, six hours before loading, and were loaded in the same line as HMW standard, 2 hours after beginning of electrophoresis to avoid mixing. HMW protein standard was stained after separation with Coomassie brilliant blue G-250. The gels were sealed in plastic bags and could be stored for several years with no loss of stain.
Lipoprotein profi les were analyzed using a laser densitometer at 632 nm with Image Master Software (version 1,0; 1993; Pharmacia). LDL peak particle sizes were calculated from the calibration curve based on the inverse relationship between the log of the known sizes of the standards on the y-axis and their migration distances from the start of the gel (Rf) on the x-axis. LDL peak particle sizes in the plasma sample absorbance profi les were calculated using Gels Scan software (56-1131-38, Pharmacia). LDL subclasses were classifi ed as phenotype A (diameter <25.5 nm) and phenotype B (diameter >25.5 nm).
Measurement of intima-media thickness
The ultrasonographic scanning of the common carotid arteries (CCA) was performed using high resolution B-mode ultrasonography (SSA-770A; Toshiba, Tokyo, Japan) with a linear array probe (7.5 MHz), according to a standardized protocol. The IMT was measured manually by using a special vernier caliper after taking a picture. The far walls of right and left common carotid artery were scanned. IMT was evaluated by measuring the linear distance, perpendicular to the luminal axis, between 2 points defi ned by the ultrasonic interface, 1 cm distal to the carotid bifurcation. CCA IMT was calculated as the mean of the right and left CCA.
Statistical analysis
The data are presented as mean  standard deviation (SD). Comparison of mean LDL particle sizes, age, plasma lipid and apoprotein concentrations between groups was performed with the two-sample unpaired Student's t-test. The differences in LDL subclass distribution between two groups were evaluated with  2 --test. Pearson correlation and multiple regression analysis were performed to investigate association between IMT and other clinical and laboratory parameters. The value of p<0.05 was considered signifi cant difference for all analyses in the study. All statistical analyses were done using STATWIN software (version 5.0 A, Statsoft Inc. 1984-95; Tulsa, OK 74104, USA).
Results
Clinical and laboratory variables of participants in study group I and study group II are shown in Table 1 .
There were no statistical differences in plasma HDL cholesterol, ApoA, ApoB, Lp(a), BMI, systolic and diastolic blood pressure between the groups.
Patients from study group II had signifi cantly higher mean total cholesterol (p<0.005), LDL cholesterol (p<0.001) and triglycerides (p<0.005) compared to study group I.
Although LDL particle size was not statistically different between two study groups, LDL size was slightly decreased (25.71±0.57 nm vs 25.02±0.86; N.S.) in CAD patients after 12 months period.
The mean IMT in all participants was 0.890.13 mm and was signifi cantly increased 12 months after the fi rst measurement (0.910.026 mm; p<0.001). Table 2 displays the LDL subclasses distribution in two study groups. In most patients from study group I (61.2 %), atherogenic phenotype B was observed due to the presence of smaller LDL subclasses as dominant subclass (LDL3 and LDL4). In 39.8 % of the patients LDL1 and LDL2 subclasses were dominant and they belonged to phenotype A. In study group II, 76 % of the patients belonged to the phenotype B, while 24 % of the patients had phenotype A.
LDL3 was the dominant subclass in both study groups, but there was statistically signifi cant difference in the distribution of dominant LDL subclasses with shift towards smaller subclasses in study group II ( 2 =4.79; p<0.01). Univariate linear regression analysis was used to determine the association of clinical and laboratory variables to CCA IMT (Tab. 3).
Correlation between the IMT and respective variables in patients from study group I (n=105) and study group II (n=95).
Of the laboratory variables, LDL size of the dominant subclass showed the strongest negative correlation with CCA IMT in both study groups. In contrast, other lipid and apoprotein plasma concentrations were not signifi cantly associated with CCA IMT in both study groups, although plasma lipid concentrations were increased in study group II. Major LDL size was strongly inversely related to the IMT of the CCA, indicating that a predominance of small LDL particles is associated with an increased IMT.
Of the clinical parameters, diastolic blood pressure (r=0.5, p< 0.05; r=0.48, p<0.05, for both study group respectively); and systolic blood pressure (r=0.49, p<0.05; r=0.51, p<0.05, for both study groups respectively) were also signifi cantly related to the CCA IMT. Age was also signifi cantly correlated with IMT in both study groups (r=0.26, p<0.05; r=0.25, p<0.05 for both study groups respectively).
Multiple regression analysis was performed to identify independent determinants of CCA IMT. Variables that were signifi cant in univariate analysis were used as independent variables in multiple regression analysis (Tab. 4).
Age, systolic, diastolic blood pressure and LDL size accounted for 29 % of the observed variability in IMT. Other variables were not independent factors for IMT. In both study groups, multiple regression analysis show that strongest independent predictor of the IMT variation was diastolic blood pressure (0.322, p=0.016; 0.324, 
Discussion
A number of studies have examined the relationship between LDL heterogeneity and CAD. In the fi rst population-based casecontrol study (29) a threefold increased risk of myocardial infarction was found in subjects with a predominance of small dense LDL particles (phenotype B). The cross-sectional studies consistently suggest an association between small dense LDL particles and CAD. A plasma concentration of small dense LDL, (above 100 mg/dL) was associated with a 4.5-fold increased risk of CAD (30) .
We used high resolution polyacrylamide gel electrophoresis to measure LDL size of the dominant subclass in CAD patients. LDL3 was dominant subclass in both study groups, but there was statistically signifi cant difference in the distribution of dominant LDL subclasses with shift towards smaller subclasses in CAD patients after 12 months period ( 2 =4.79; p<0.01). Although LDL particle size was not statistically different between two study groups, mean LDL size was slightly decreased in CAD patients after 12 months period.
Our results were in agreement with other case-control studies reporting an increased prevalence of small LDL particles (phenotype B) in patients with coronary artery disease (26, 29, 30,3 1) , and confi rmed the association of small LDL particles and coronary artery disease.
An increased IMT is considered a reliable marker of early atherosclerosis (25) . Increased carotid IMT and its progression are associated with cardiovascular risk factors (32) . Therefore, we measured IMT using high resolution B-mode ultrasonography to estimate atherosclerosis and its progression in CAD patents at their fi rst visit and after 12 months. The mean IMT in all participants was 0.890.13 mm and was signifi cantly increased 12 months after the fi rst measurement (0.910.026 mm; p<0.001).
In our study, we also demonstrated that LDL size is strongly associated with IMT of the carotid arteries and multivariate analysis revealed that LDL size was the second strongest predictor of IMT, after diastolic blood pressure. The association is shown to be independent of plasma LDL concentration and together with diastolic blood pressure and age accounted for 29 % of the observed variability in IMT. This association was observed in CAD patients at their fi rst visit (study group I), and after 12 months (study group II) which indicates that LDL size is a good marker of atherosclerosis progression.
In line with our results, LDL particle size has been reported to be associated with carotid IMT in middle-aged subjects in the study of Skoglund et al (30) and Hulthe et al (31, 33) .
It has been demonstrated that small LDLs are independently related to common carotid artery IMT (30, 32, 34) . In the study of Liu et al (24) , LDL particle size correlated signifi cantly with mean IMT even after adjustment for age, BMI and sex. Results from their multivariate analysis demonstrate that LDL particle size is independently associated with mean IMT.
Several pathophysiological mechanisms for the increased atherogenecity of small LDL have been suggested. Compared with larger and more buoyant LDL particles small LDL more readily infi ltrate the arterial wall, bind more tightly to arterial wall proteoglycans and are more susceptible to oxidative modifi cation (35, 36,3 7) .
Furthermore, small dense LDL particles have a prolonged plasma residence time most probably due to a decreased affi nity for the LDL receptor and in effect an extended opportunity to exert atherogenic effect (36) .
Although the metabolic origin of small dense LDL is not fully understood, the distribution of LDL particle size in human plasma is believed to be the result of the coordinated actions of hepatic and endothelial lipases as well as mediators of neutral lipid exchange (38, 39) .
In conclusion, our results suggest that LDL particle size is signifi cantly associated with carotid IMT in CAD patients independent of traditional lipid and established risk factors. Small dense LDL particles play an important role in causing vascular change, leading to atherosclerosis. Our results indicate that the evaluation of LDL particle size distribution with a high-resolution polyacrylamide gel electrophoresis may be a valuable approach to estimate individual cardiovascular risk and predictor of atherosclerosis progression in patients with established atherosclerosis as well as in asymptomatic individuals. Such follow-up may facilitate the directed development of preventive strategies.
